nForm Blog
A discussion on advances in biomarker research
Infectious Disease Publication Watch
COVID-19: The Fall Edition
Normally, the months of September and October are dotted with important dates—end of summer barbeques, the first day of school, joyful plans for Halloween and excitement for the upcoming Holiday…
Q&A Services and Core Labs
Vision, Cutting-Edge Technology, and Deep Expertise. Interview with the Scientists at Propath UK, the Royals Among the CROs.
A few years ago, the UK Prime Minister’s office announced that Propath, a trusted specialist in molecular pathology for biopharmaceutical research and development, had been nominated to receive a Queen’s…
Q&A
ROSALIND® by OnRamp Bio: A new platform for nCounter® expression analysis.
Recently NanoString® has announced its partnership with OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, to integrate our knowledge and expertise into an optimized analysis experience for nCounter with…
Oncology
From an Egyptian Papyrus to the Hallmarks of Cancer: A Journey through the Development of Knowledge in Oncology Research
The word “cancer” was used for the first time in ancient Greece by Hippocrates, often termed the Father of Medicine for his contributions to modern medical practice. Even prior to…
Q&A Services and Core Labs
Serotonin, Gut-Brain-Microbiome Axis and an Inspired Young Scientist. How a Core Facility is Born. Q&A with Prof. Beate Niesler, Institute of Human Genetics, University of Heidelberg, Germany.
Imagine you are setting up for an interview with a prominent professor at the University of Heidelberg in Germany, in which you will focus on how a scientific interest triggered…
Grants Q&A Transplant
Molecular Signatures of Antibody-Mediated Rejection and Graft Outcome After Kidney Transplantation. Q&A with Dr. Dela Golshayan, M.D., Ph.D.
When Newsweek Magazine rates you the 9th best Hospital in the World, you know you are doing something remarkable! Located in Lausanne, Switzerland, Lausanne University Hospital (CHUV) sits on Lake Geneva…
Grants Q&A
All Things Grants. Q&A with a Grant Reviewer and two Grant Writers – Tips & Tricks for Success.
“An advice I would give to a beginner grant writer is to take the reviewer by hand, take him one step at the time in a logical fashion through that…
Digital Spatial Profiling Q&A Services and Core Labs
Excellence, Cooperation, and Passion Come Together to Serve the Scientific Community. Q&A with Dr. Peter O’Toole, Director of the Bioscience Technology Facility, University of York.
Dr. Peter O’Toole, Ph.D., is the director of the Bioscience Technology Facility at the University of York in England, where he established and still leads the Imaging and Cytometry Laboratory, one of the…
Oncology Panels Q&A
Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people…
Immunity Infectious Disease Publication Watch
COVID-19 Pathogenesis Steps Out of the Shadows
“Analysis of pulmonary vessels showed that widespread thrombosis with microangiopathy ─ a severe condition wherein small blood clots are formed within the tiniest of blood vessels ─ was 9x more…
Panels Q&A Services and Core Labs
Spotlight on a CRO: Interview with the Team of Scientists behind NeoGenomics Pharma Services.
NeoGenomics is a cancer diagnostics and pharma services company serving pharmaceutical companies and academic centers. They specialize in diagnostic, prognostic and predictive testing using the most innovative technologies. The company…
Oncology Q&A
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…